Lars Hansen-Kjoller

Roskilde, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Linking Lipidomics to Vulnerable Coronary Plaques: A PROSPECT II Substudy.

Linking Lipidomics to Vulnerable Coronary Plaques: A PROSPECT II Substudy.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: June 25, 2026

Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy.

Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy.

Journal: Circulation

Published: June 23, 2025

Circulating protein biomarkers and their association with vulnerable plaque characteristics - a PROSPECT II substudy.

Circulating protein biomarkers and their association with vulnerable plaque characteristics - a PROSPECT II substudy.

Journal: International journal of cardiology. Cardiovascular risk and prevention

Published: March 12, 2025

Coronary CT angiography is a safe gatekeeper in non-ST-elevation acute coronary syndrome - The VECTOR study.

Coronary CT angiography is a safe gatekeeper in non-ST-elevation acute coronary syndrome - The VECTOR study.

Journal: The international journal of cardiovascular imaging

Published: February 20, 2025

Lipoprotein(a), Cholesterol, Triglyceride Levels, and Vulnerable Coronary Plaques: A PROSPECT II Substudy.

Lipoprotein(a), Cholesterol, Triglyceride Levels, and Vulnerable Coronary Plaques: A PROSPECT II Substudy.

Journal: Journal of the American College of Cardiology

Published: February 06, 2025

10-year follow-up of patients treated with catheter-based renal denervation for resistant hypertension: an observational study.

10-year follow-up of patients treated with catheter-based renal denervation for resistant hypertension: an observational study.

Journal: BMC cardiovascular disorders

Published: January 14, 2025

Impact of Lipidic Plaque on In-Stent and Stent Edge-Related Events After PCI in Myocardial Infarction: A PROSPECT II Substudy.

Impact of Lipidic Plaque on In-Stent and Stent Edge-Related Events After PCI in Myocardial Infarction: A PROSPECT II Substudy.

Journal: Circulation. Cardiovascular interventions

Published: September 25, 2024

Relationships of hsCRP to High-Risk Vulnerable Plaque After NSTEMI: Insights From the PROSPECT II Trial.

Relationships of hsCRP to High-Risk Vulnerable Plaque After NSTEMI: Insights From the PROSPECT II Trial.

Journal: JACC. Cardiovascular interventions

Published: May 26, 2024

Association Between Physiological Significance and Vulnerable Plaque Characteristics in Patients With Myocardial Infarction: A Prospect II Substudy.

Association Between Physiological Significance and Vulnerable Plaque Characteristics in Patients With Myocardial Infarction: A Prospect II Substudy.

Journal: JACC. Cardiovascular imaging

Published: April 14, 2024

Coronary Artery Lesion Lipid Content and Plaque Burden in Diabetic and Nondiabetic Patients: PROSPECT II.

Coronary Artery Lesion Lipid Content and Plaque Burden in Diabetic and Nondiabetic Patients: PROSPECT II.

Journal: Circulation

Published: December 16, 2022

Predictors of 10-Year Stent-Related Adverse Outcomes after Coronary Drug-Eluting Stent Implantation: The Importance of Stent Size.

Predictors of 10-Year Stent-Related Adverse Outcomes after Coronary Drug-Eluting Stent Implantation: The Importance of Stent Size.

Journal: Cardiology

Published: January 25, 2021

Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study.

Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study.

Journal: Lancet (London, England)

Published: November 11, 2020

Showing 1-12 of 17

Last Updated: 09/26/2026